Synthesis and Investigation of Mixed μ‐Opioid and δ‐Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain
- 1 June 2016
- journal article
- research article
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 54 (2) , 1228-1235
Abstract
Several studies have suggested functional association between μ‐opioid and δ‐opioid receptors and showed that μ‐activity could be modulated by δ‐ligands. The general conclusion is that agonists for the δ‐receptor can enhance the analgesic potency and efficacy of μ‐agonists. Our preliminary investigations demonstrate that new bivalent ligands constructed from the μ‐agonist fentanyl and the δ‐agonist enkephalin‐like peptides are promising entities for creation of new analgesics with reduced side effects for treatment of neuropathic pain. A new superposition of the mentioned pharmacophores led to novel μ‐bivalent/δ‐bivalent compounds that demonstrate both μ‐opioid and δ‐opioid receptor agonist activity and high efficacy in anti‐inflammatory and neuropathic pain models with the potential of reduced unwanted side effects.Keywords
Funding Information
- U.S. Public Health Service National Institute of Health (13449, 06284, 06789)
This publication has 49 references indexed in Scilit:
- Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-TicEuropean Journal of Medicinal Chemistry, 2011
- Mix and Match: Heterodimers and Opioid ToleranceNeuron, 2011
- Development of Potent μ and δ Opioid Agonists with High LipophilicityJournal of Medicinal Chemistry, 2010
- Bi- or multifunctional opioid peptide drugsLife Sciences, 2010
- Receptor heteromerization and drug discoveryTrends in Pharmacological Sciences, 2010
- Evolution of the Bifunctional Lead μ Agonist/δ Antagonist Containing the 2′,6′-Dimethyl-l-tyrosine−1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid (Dmt−Tic) Opioid PharmacophoreACS Chemical Neuroscience, 2009
- Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat PainCell, 2009
- Development of Novel Enkephalin Analogues that Have Enhanced Opioid Activities at Both μ and δ Opioid ReceptorsJournal of Medicinal Chemistry, 2007
- Opioid and melanocortin receptors: Do they have overlapping pharmacophores?Biopolymers, 2007
- Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at μ and δ opioid receptorsBioorganic & Medicinal Chemistry Letters, 2007